156 related articles for article (PubMed ID: 32266659)
21. Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.
Yoshino H; Enokida H; Itesako T; Tatarano S; Kinoshita T; Fuse M; Kojima S; Nakagawa M; Seki N
J Hum Genet; 2013 Aug; 58(8):508-16. PubMed ID: 23635949
[TBL] [Abstract][Full Text] [Related]
22. MiR-30b-5p functions as a tumor suppressor in cell proliferation, metastasis and epithelial-to-mesenchymal transition by targeting G-protein subunit α-13 in renal cell carcinoma.
Liu W; Li H; Wang Y; Zhao X; Guo Y; Jin J; Chi R
Gene; 2017 Aug; 626():275-281. PubMed ID: 28536082
[TBL] [Abstract][Full Text] [Related]
23. MiR-29c suppresses cell invasion and migration by directly targeting CDK6 in gastric carcinoma.
Jiang H; Liu ZN; Cheng XH; Zhang YF; Dai X; Bao GM; Zhou LB
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7920-7928. PubMed ID: 31599417
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
Ye J; Li L; Feng P; Wan J; Li J
Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-15 suppresses viability, migration and invasion of the human MG-63 osteosarcoma cells via inhibition of cyclin dependent kinase 6 (CDK6).
Shen Z; Wang C; Liu B; Du J; Li Z; Zhao J
Acta Biochim Pol; 2022 Oct; 69(4):761-766. PubMed ID: 36272153
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells.
Park YR; Lee ST; Kim SL; Zhu SM; Lee MR; Kim SH; Kim IH; Lee SO; Seo SY; Kim SW
Cancer Genet; 2019 Feb; 231-232():22-31. PubMed ID: 30803553
[TBL] [Abstract][Full Text] [Related]
27. miR-148a suppresses human renal cell carcinoma malignancy by targeting AKT2.
Cao H; Liu Z; Wang R; Zhang X; Yi W; Nie G; Yu Y; Wang G; Zhu M
Oncol Rep; 2017 Jan; 37(1):147-154. PubMed ID: 27878305
[TBL] [Abstract][Full Text] [Related]
28. miR-326 functions as a tumor suppressor in human prostatic carcinoma by targeting Mucin1.
Liang X; Li Z; Men Q; Li Y; Li H; Chong T
Biomed Pharmacother; 2018 Dec; 108():574-583. PubMed ID: 30243091
[TBL] [Abstract][Full Text] [Related]
29. miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma.
Mao Y; Liu J; Zhang D; Li B
Tumour Biol; 2016 Jul; 37(7):9009-22. PubMed ID: 26758433
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-504 functions as a tumor suppressor in oral squamous cell carcinoma through inhibiting cell proliferation, migration and invasion by targeting CDK6.
Wang X; Chang K; Gao J; Wei J; Xu G; Xiao L; Song G
Int J Biochem Cell Biol; 2020 Feb; 119():105663. PubMed ID: 31812760
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-497 suppresses renal cell carcinoma by targeting VEGFR-2 in ACHN cells.
Pengcheng S; Ziqi W; Luyao Y; Xiangwei Z; Liang L; Yuwei L; Lechen L; Wanhai X
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465356
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of TUG1 by shRNA inhibited renal cell carcinoma formation by miR-299-3p/VEGF axis in vitro and in vivo.
Li Y; Zheng D; Pan L; Dai Y; Cai S; Zhao L; Zhu H
Eur J Pharmacol; 2019 Oct; 860():172536. PubMed ID: 31310753
[TBL] [Abstract][Full Text] [Related]
33. miR-33a inhibits cell growth in renal cancer by downregulation of MDM4 expression.
Jiang K; Sun F; Zhu J; Luo G; Ban Y; Zhang P
Mol Genet Genomic Med; 2019 Aug; 7(8):e833. PubMed ID: 31250570
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-506 inhibits the proliferation and invasion of mantle cell lymphoma cells by targeting B7H3.
Zhu XW; Wang J; Zhu MX; Wang YF; Yang SY; Ke XY
Biochem Biophys Res Commun; 2019 Jan; 508(4):1067-1073. PubMed ID: 30553455
[TBL] [Abstract][Full Text] [Related]
35. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-21 functions as an oncogene and promotes cell proliferation and invasion via TIMP3 in renal cancer.
Chen J; Gu Y; Shen W
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4566-4576. PubMed ID: 29131259
[TBL] [Abstract][Full Text] [Related]
37. miR-3613-5p enhances the metastasis of pancreatic cancer by targeting CDK6.
Cao R; Wang K; Long M; Guo M; Sheng L; Zhan M; Yang R; Wang H; Yang L
Cell Cycle; 2020 Nov; 19(22):3086-3095. PubMed ID: 33073681
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA‑212 inhibits the proliferation and invasion of human renal cell carcinoma by targeting FOXA1.
Tong Z; Meng X; Wang J; Wang L
Mol Med Rep; 2018 Jan; 17(1):1361-1367. PubMed ID: 29115609
[TBL] [Abstract][Full Text] [Related]
39. miR-636 represses cell survival by targeting CDK6/Bcl-2 in cervical cancer.
Hu QL; Xu ZP; Lan YF; Li B
Kaohsiung J Med Sci; 2020 May; 36(5):328-335. PubMed ID: 31889428
[TBL] [Abstract][Full Text] [Related]
40. miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells.
Feng L; Xie Y; Zhang H; Wu Y
Med Oncol; 2012 Jun; 29(2):856-63. PubMed ID: 21264532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
